Back to search
Cancer Disease Progression
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Cancer Disease Progression trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Cancer Disease Progression trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Background: Active surveillance (AS) is a standard approach to treat low and intermediate risk prostate cancer. For AS, disease progression is monitored. AS us…
Background: Lung cancer is the leading cause of cancer-related death worldwide. Non-small cell lung cancer (NSCLC) is the most common type of lung cancer. Surg…
The present study aims to conduct a randomized controlled trial to assess the effect of CALM intervention and ConquerFear intervention on fear of cancer progres…
This phase II trial studies whether different imaging techniques can provide additional and more accurate information than the usual approach for assessing the…
Background: Adrenocortical carcinoma (ACC) is a rare cancer of the adrenal glands. ACC often returns after tumors are removed with surgery. Less than 35% of pe…
The goal of the AXIS Autoimmune Neurology Registry is to learn about the experiences of adults living with autoimmune neurological disorders, starting with myas…
Background: Thymoma and thymic carcinoma are cancers originating in the thymus gland. Platinum-based chemotherapy is standard treatment for them. But not uncom…
The purpose of the study is to assessed the efficiency of treatment based on the objective response rate (RECIST 1.1)